FEATURED 2020 SPEAKERS

 

2020 SPEAKERS

 

Hinrich Abken, Chair for Genetic Immunotherapy, University Hospital Regensburg

Elsa Abranches, Group Leader, Section Of Stem Cell Biology, UK Stem Cell Bank, NIBSC

Prasad Adusumilli, Deputy Chief And Associate Attending, Thoracic Surgery Director, Mesothelioma Program, Memorial Sloan-Kettering Cancer Center

Joachim Aerts, Head of the Department, Professor of Pulmonary Medicine, Pulmonary Diseases, Erasmus M.C.

Pinar Akcakaya, Senior Research Scientist, AstraZeneca

Pinar Akcakaya | Senior Research Scientist | AstraZeneca » speaking at Advanced Therapies

Stephen Badylak, Deputy Director, Mcgowan Institute For Regenerative Medicine, University of Pittsburgh

Frank Barry, Scientific Director, Regenerative Medicine Institute

Frank Barry | Scientific Director | Regenerative Medicine Institute » speaking at Advanced Therapies

Dr Roy Baynes, Senior Vice President And Head Global Clinical Development, Chief Medical Officer, Merck Sharp and Dohme (MSD)

Elena Beltrami, Business Development Manager, Fondazione Telethon

David Blakey, Chief Scientific Officer, Mina Therapeutics

Axel Boehnke, Director Market Access Eu North, PTC Therapeutics

Jaap Boelens, Chief; Stem Cell Transplantation And Cellular Therapies Pediatrics, Memorial Sloan-Kettering Cancer Center

Luc Boileau, Chairman And Chief Executive Officer, INESSS

Luc Boileau | Chairman And Chief Executive Officer | INESSS » speaking at Advanced Therapies

Todd C Mcdevitt, Professor, Gladstone Institute

Todd C Mcdevitt | Professor | Gladstone Institute » speaking at Advanced Therapies

Didier Caizergues, Director Of Regulatory Affairs, Genethon

John Campbell, Associate Director, Tissues, Cells And Advanced Therapeutics, Scottish National Blood Transfusion Service

Manuel Carrondo, Professor, iBET: Instituto de Biologia Experimental e Tecnológica

Paul S Carter, Cell And Gene Therapy Platform Cmc, GlaxoSmithKline

Paul S Carter | Cell And Gene Therapy Platform Cmc | GlaxoSmithKline » speaking at Advanced Therapies

Vittorio Colizzi, Professor Of Immunology, University of Rome Tor Vergata

Vittorio Colizzi | Professor Of Immunology | University of Rome Tor Vergata » speaking at Advanced Therapies

Jean-Philippe Combal, Co-Founder And Chief Executive Officer, Vivet Therapeutics

Elena Costariol, Engd Researcher, UCL

Christina Coughlin, Chief Medical Officer, Tmunity Therapeutics

Conrad Russell Y Cruz, Translational Research Laboratories Director, Children's National Medical Center

Armando Cuesta Díaz, Partner, Ilana Capital

Davide Danovi, Director, Hipsci Cell Phenotyping Programme, King's College London

Eric Michael David, Chief Executive Officer-In-Residence, Gene Therapy, BridgeBio-Gene Therapy

Chirag Desai, Director, Chronic Pancreatitis & Autologous-Islet Cell Transplant Program,, University Of North Carolina School Of Medicine

Joe Dupere, Chief Executive Officer, Rexgenero Ltd..

Kris Elverum, Senior Vice President Of Business Development And Strategy, Rubius Therapeutics

Kris Elverum | Senior Vice President Of Business Development And Strategy | Rubius Therapeutics » speaking at Advanced Therapies

Victoria English, Victoria English, Co-Founder And Editor, Evernow Publications

Debora Esposito, Phd Candidate, N.C. State University

Debora Esposito | Phd Candidate | N.C. State University » speaking at Advanced Therapies

Prof Farzin Farzaneh, Professor Of Molecular Medicine, King's College Hospital

Hans-Juergen Fuelle, NIBR, Global Therapeutic Area Lead RA Early Development, Novartis

Hans-Juergen Fuelle | NIBR, Global Therapeutic Area Lead RA Early Development | Novartis » speaking at Advanced Therapies

Michela Gabaldo, Head Of Alliance Management, Fondazione Telethon

André Gerth, R&D, Famicord Group

Faruque Ghanchi, Consultant Ophthalmologist, Head, Bradford Ophthalmology Research Network (BORN), Specialty Lead- Ophthalmology,, Bradford Teaching Hospitals N.H.S. Foundation Trust

Faruque Ghanchi | Consultant Ophthalmologist, Head, Bradford Ophthalmology Research Network (BORN), Specialty Lead- Ophthalmology, | Bradford Teaching Hospitals N.H.S. Foundation Trust » speaking at Advanced Therapies

Dr David Gilham, Vice President Of Research And Development, Celyad

Janet Glassford, Quality Assessor, Medicines & Healthcare Products Regulatory Agency

Janet Glassford | Quality Assessor | Medicines & Healthcare Products Regulatory Agency » speaking at Advanced Therapies

Cecilia Gotherstrom, Research Leader And Associate Professor, Karolinska Institute

Julian Gough, Chief Scientific Officer, Mogrify

Lise Marie Grav, Postdoc, Technical University of Denmark

Uta Griesenbach, Professor Of Molecular Medicine, Imperiai College London

Ravindra Gupta, Wellcome Trust Senior Fellow In Clinical Science, Ucl Division Of Infection And Immunity, UCL

Ravindra Gupta | Wellcome Trust Senior Fellow In Clinical Science, Ucl Division Of Infection And Immunity | UCL » speaking at Advanced Therapies

Sam Hall, Partner, Apple Tree Partners

Sam Hall | Partner | Apple Tree Partners » speaking at Advanced Therapies

Patrick J Hanley, Director, Cellular Therapy Laboratory, Children's National Medical Center

Patrick J Hanley | Director, Cellular Therapy Laboratory | Children's National Medical Center » speaking at Advanced Therapies

Hansjörg Hauser, Head Of Department Of Scientific Strategy, Helmholtz Centre for Infection Research GmbH

Frank Hecht, Vice President Marketing And Sales, CellGenix GmbH

Dawn Henke, Senior Technical Program Manager, Standards Coordinating Body

Dawn Henke | Senior Technical Program Manager | Standards Coordinating Body » speaking at Advanced Therapies

Christoph Herwig, Professor Of Biochemical Engineering, Vienna University of Technology

Edward Hodgkin, Partner, Syncona Partners

Annie Hubert, Director, European Public Policy, Alliance for Regenerative Medicine

Annie Hubert | Director, European Public Policy | Alliance for Regenerative Medicine » speaking at Advanced Therapies

Bjarki Johannesson, Senior Research Investigator, The New York Stem Cell Foundation

Troels Jordansen, Chief Executive Officer, Glycostem

Margareth Jorvid, Head Of Regulatory Affairs and QA, Immunicum

Margareth Jorvid | Head Of Regulatory Affairs and QA | Immunicum » speaking at Advanced Therapies

Vaidehi Joshi, Scientist II, Therapeutics,, Organovo

Steve Kanner, Chief Scientific Officer, Caribou Bio

Dr Bo Kara, VP Process Development, Evox Therapeutics

Cornelia Kasper, Professor, Biopharmaceutical Production And Technology, B.O.K.U.

Hans Keirstead, Chief Executive Officer, AIVITA Biomedical

Sven Kili, Vice President And Head Of Gene Therapy Development, Sven Kili Consulting

Sven Kili | Vice President And Head Of Gene Therapy Development | Sven Kili Consulting » speaking at Advanced Therapies

Soekjoong Kim, R&D Managing Director, ToolGen

Seokjoong Kim, Executive Director of R&D and Strategic Alliances, ToolGen

Seokjoong Kim | Executive Director of R&D and Strategic Alliances | ToolGen » speaking at Advanced Therapies

Katja Kleinsteuber, Scientist II, Cellular Analytics, bluebird bio

Jarema (Jarko) Kochan, Head Of Biomarkers, Diagnostics And Assay Development, Turnstone Biologics

Shane Kovacs, Chief Business Officer And Chief Financial Officer, BlueRock Therapeutics

Shane Kovacs | Chief Business Officer And Chief Financial Officer | BlueRock Therapeutics » speaking at Advanced Therapies

Sebastian Kress, Post Doc, BOKU

Jurgen Kuball, Professor, UMC Utrecht

Jurgen Kuball | Professor | UMC Utrecht » speaking at Advanced Therapies

Dmitry Kuzmin, Managing Partner, 4Bio Capital

Lawrence Lamb, Executive Vice President And Chief Scientific Officer, Incysus Therapeutics

Christine Le Bec, Head Of Analytical Development, Genethon

Christine Le Bec | Head Of Analytical Development | Genethon » speaking at Advanced Therapies

Chaim Lebovits, Chief Executive Officer, Brainstorm Cell Therapeutics Inc

Steven Lee, Senior Research Fellow, Institute of Immunology and Immunotherapy, University of Birmingham

Dave Lennon, President, AveXis

Frank Luyten, Director, Katholeieke Universiteit Leuven

Dr Danilo Maddalo, Laboratory Head, Novartis Institutes for Biomedical Research

John Maher, Chief Scientific Officer, Leucid Bio

Dawn Maier, Sr. Director Process Development and Manufacturing, ElevateBio

Sakis Mantalaris, Professor, Biomedical Systems Engineering Laboratory, Georgia Institute of Technology

David Mazzo, Chief Executive Officer, Caladrius Biosciences

Aisleen Mccoll-Carboni, Senior Scientist, Sanofi

Aisleen Mccoll-Carboni | Senior Scientist | Sanofi » speaking at Advanced Therapies

Joanna Miller, Chief Scientific Officer, Cell Therapy Sciences

Joanna Miller | Chief Scientific Officer | Cell Therapy Sciences » speaking at Advanced Therapies

Federico Mingozzi, Chief Scientific Officer, Spark Therapeutics

Federico Mingozzi | Chief Scientific Officer | Spark Therapeutics » speaking at Advanced Therapies

Maria Mirotsou, Senior Director, Research, Astellas Pharma

Maria Mirotsou | Senior Director, Research | Astellas Pharma » speaking at Advanced Therapies

Jennifer Moody, Senior Director, Research Operations, BlueRock Therapeutics

Neill Moray Mackenzie, Chairman And Board Mamber, Immetacyte

Neill Moray Mackenzie | Chairman And Board Mamber | Immetacyte » speaking at Advanced Therapies

David Morrow, Program Manager, EATRIS

Mary Murphy, Principle Investigator, Remedi National University of Ireland Galway

Mary Murphy | Principle Investigator | Remedi National University of Ireland Galway » speaking at Advanced Therapies

Alexander Natz, Secretary General, European Confederation of Pharmaceutical Entrepreneurs (Belgium)

Jelena Ochs, Manager Business Unit Life Sciences Engineering, Fraunhofer Institute for Production Technology

Daniel O'Mahony, Partner, Seroba Life Sciences

Dominic O'Reagan, Director And Investor, New Mosaic

Palani Palaniappan, Head Of Technical Operations And Andover Site, Sarepta Therapeutics

Ioannis Papantoniou, Adjunct Professor, KU Leuven

Detlev Parow, Head Pharmaceutical Department, D.A.K.

Leonard Pattenden, Head Of Biotherapeutics Development And Drug Supply Biotherapeutics Development Unit, Cancer Research UK

C. David Pauza, Chief Science Officer, American Gene Technologies International Inc.

Sergey Piletsky, Professor, University of Leicester

Sergey Piletsky | Professor | University of Leicester » speaking at Advanced Therapies

Roland Pochet, Professor, Universite Libre De Bruxelles

Dr Qasim Rafiq, Associate Professor, Bioprocessing Of Cell And Gene Therapies, University College London

Lior Raviv, Vice President Of Development, Pluristem Therapeutics

Albert Ribickas, Bmt/Qc Laboratories Manager, Cell Therapies Facility, Moffitt Cancer Center

Jim Richardson, Senior Science and Standards Liaison, U.S. Pharmacopeia

Jim Richardson | Senior Science and Standards Liaison | U.S. Pharmacopeia » speaking at Advanced Therapies

Dr Barry Rosen, Senior Principal Scientist And Director, AstraZeneca

Igor Rudychev, Head Of Us Digital, Data, And Innovations, AstraZeneca

Igor Rudychev | Head Of Us Digital, Data, And Innovations | AstraZeneca » speaking at Advanced Therapies

David Schaffer, Professor, Chemical and Biomolecular Engineering, University of California, Berkeley, and Co-Founder,, 4D Molecular Therapeutics

Dominic Schmidt, Partner, Syncona Investment Management Ltd

Elizabeth Schwarzbach, Chief Business Officer, The New York Stem Cell Foundation

Ra Session II, Chief Business Officer, BridgeBio-Gene Therapy

Ra Session II | Chief Business Officer | BridgeBio-Gene Therapy » speaking at Advanced Therapies

Andrew Sewell, Professor, Infection And Immunity, Cardiff University

Andrew Sewell | Professor, Infection And Immunity | Cardiff University » speaking at Advanced Therapies

Ilya Shestopalov, Associate Director, Cell Analytics, bluebird bio

Owen Smith, Principal, 4Bio Capital

Owen Smith | Principal | 4Bio Capital » speaking at Advanced Therapies

Devyn Smith, Chief Strategy Officer And Head Of Operations, Sigilon

Alan Smith, Executive Vice President, Technical Operations, Bellicum Pharmaceuticals

Eric Soller, Vice President Of Corporate Development And Strategy, BlueRock Therapeutics

Fatima Sulaiman, Head Of Research And Services, Scleroderma and Raynaud's UK

Lawrence Thompson, Senior Principal Scientist, Analytical Research and Development, Pfizer

Evelina Vågesjö, CEO, Ilya Pharma

Dr Bob Valamehr, Chief Development Officer, Fate Therapeutics

Johannes Van Der Loo, Clinical Vector Core Director, The Children's Hospital of Philadelphia

Edward Van Wezel, Managing Partner, Bgv Biogeneration Ventures

Dr Alain Vertes, Managing Director, NxR Biotechnologies

Wen Bo Wang, Senior Vice President Of Technical Operations, Fate Therapeutics

Wen Bo Wang | Senior Vice President Of Technical Operations | Fate Therapeutics » speaking at Advanced Therapies

Dr Michael West, Founder and CEO, AgeX Therapeutics

Adrian Woolfson, Executive Vice President, Research and Development, Sangamo Theraputics

Fraser Wright, Professor (Research), Pediatrics, Stanford University

Fraser Wright | Professor (Research), Pediatrics | Stanford University » speaking at Advanced Therapies

Dr Masahide Yano, Research Scientist, U.S. Food and Drug Administration

Stefano Zancan, Head Clinical Development And Operations, Fondazione Telethon

 

 

 

 

“Let me congratulate you on a job well done in helping organise the speakers and presentations for last week's Advanced Therapies Congress. I thought the entire meeting had a lot of substance, which made it stand out from many other meetings.”

 

Editor, Evernow Publishing Ltd